Zenzium provides core AI capabilities for COVID-19 collaboration

Macclesfield, England--(BUSINESS WIRE)--Zenzium, Ltd., announced today it is to provide the core Artificial Intelligence (AI) capabilities for a Manchester-based trial sponsored by The Christie NHS Foundation Trust together with the Manchester University NHS Foundation Trust (MFT) with additional participation from Aptus Clinical. The COSMIC-19 (COntinious Signs Monitoring In Covid-19 patients) pilot study aims to recruit 60 inpatients on general wards who are suspected or confirmed to have COV